Central nervous system abnormalities in patients with PMP22 gene mutations: A prospective study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 4, 2013, Pages 392-397

  Chanson, Jean Baptiste ^a,b   Echaniz Laguna, Andoni ^a   Blanc, Frédéric ^a,b   Lacour, Arnaud ^c   Ballonzoli, Laurent ^d   Kremer, Stéphane ^b,d   Namer, Izzie Jacques ^d   Lannes, Béatrice ^d   Tranchant, Christine ^a   Vermersch, Patrick ^c   De Seze, Jérôme ^a,b  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID; PERIPHERAL MYELIN PROTEIN 22;

ADULT; ARTICLE; AUTOPSY; BRAIN LEVEL; BRAIN SIZE; CENTRAL NERVOUS SYSTEM DISEASE; CHARCOT MARIE TOOTH 1A DISEASE; CLINICAL ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FRACTIONAL ANISOTROPY; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GRAY MATTER; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSY; HUMAN; HUMAN TISSUE; MALE; METABOLIC DISORDER; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NONSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PMP22 GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; WHITE MATTER;

EID: 84875227833     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303725     Document Type: Article

References (26)

1. Snipes GJ, Suter U, Welcher AA, et al. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 1992;117: 225-38.
2. Naef R, Suter U. Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc Res Tech 1998;41:359-71. (Pubitemid 28308900)
3. Saporta AS, Sottile SL, Miller LJ, et al. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011;69:22-33.
4. Mouton P, Tardieu S, Gouider R, et al. Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology 1999;52: 1440-6. (Pubitemid 29190538)
5. Birouk N, Gouider R, Le Guern E, et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 1997;120:813-23. (Pubitemid 27222986)
6. Ohsawa Y, Murakami T, Miyazaki Y, et al. Peripheral myelin protein 22 is expressed in human central nervous system. J Neurol Sci 2006;247:11-15. (Pubitemid 44107377)
7. De Gasperi R, Gama Sosa MA, Naumowicz Z, et al. Peripheral myelin protein 22 is expressed in CNS myelin. Transl Neurosci 2010;1:282-5.
8. Amato AA, Barohn RJ. Hereditary neuropathy with liability to pressure palsies: association with central nervous system demyelination. Muscle Nerve 1996;19:770-3. (Pubitemid 26134589)
9. Panas M, Karadima G, Kalfakis N, et al. Charcot-Marie-Tooth disease type 1A with central nervous system involvement in two generations. J Neurol 2004;251:484-5. (Pubitemid 38501312)
10. Sanahuja J, Franco E, Rojas-García R, et al. Central nervous system involvement in hereditary neuropathy with liability to pressure palsies: description of a large family with this association. Arch Neurol 2005;62:1911-14. (Pubitemid 41785085)
11. Tackenberg B, Möller JC, Rindock H, et al. CNS involvement in hereditary neuropathy with pressure palsies (HNPP). Neurology 2006;67:2250-2. (Pubitemid 46035490)
12. Latour P, Boutrand L, Levy N, et al. Polymorphic short tandem repeats for diagnosis of the Charcot-Marie-Tooth 1A duplication. Clin Chem 2001;47:829-37. (Pubitemid 32398033)
13. Merkies IS, Schmitz PI, van der Meché FG, et al. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2002;72:596-601. (Pubitemid 34462813)
14. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479-89.
15. Dong Q, Welsh RC, Chenevert TL, et al. Clinical applications of diffusion tensor imaging. J Magn Reson Imaging 2004;19:6-18. (Pubitemid 38055724)
16. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31: 1487-505.
17. Beck A, Ward C, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
18. Dujardin K, Sockeel P, Cabaret M, et al. BCcogSEP: a French test battery evaluating cognitive functions in multiple sclerosis. Rev Neurol (Paris) 2004;160:51-62. (Pubitemid 38315600)
19. Blanc F, Noblet V, Jung B, et al. White matter atrophy and cognitive dysfunctions in neuromyelitis optica. PLoS One 2012;7:e33878; Epub 2012 Apr 3.
20. Rao SM, Leo GJ, Bernardin L, et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685-91.
21. Wechsler D. Wechsler adult intelligence scale-revised manual. New York: The Psychological Corporation, 1981.
22. Thomas AG, Koumellis P, Dineen RA. The fornix in health and disease: an imaging review. Radiographics 2011;31:1107-21.
23. Sargiannidou I, Vavlitou N, Aristodemou S, et al. Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects. J Neurosci 2009;29:4736-49.
24. Echaniz-Laguna A, Degos B, Bonnet C, et al. NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement. Neuromuscul Disord 2007;17:163-8. (Pubitemid 46274371)
25. Meyer Zu Hörste G, Nave KA. Animal models of inherited neuropathies. Curr Opin Neurol 2006;19:464-73.
26. Kirov G, Grozeva D, Norton N, et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet 2009;18:1497-503.